Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 614, pseudogene (RN7SL614P)

Target
RN7SL614P
Molecular classification
Other (Pseudogene; not a protein, enzyme, receptor, transporter, or transcription factor)
01

Overview

RNA, 7SL, cytoplasmic 614, pseudogene (RN7SL614P) is a truncated, non-functional copy of the 7SL RNA gene, present in the human genome as a result of reverse transcription events and is classified as a pseudogene rather than a protein-coding gene or functional non-coding RNA[1][4]. Pseudogenes like RN7SL614P do not produce functional RNA molecules and are not considered drug targets, nor do they have established roles in normal biology or disease. The canonical 7SL RNA, however, is the RNA component of the Signal Recognition Particle (SRP), a key ribonucleoprotein complex that directs nascent proteins to the endoplasmic reticulum during translation[2][3]. Variants and processed fragments of canonical 7SL RNA are implicated in translational regulation and viral RNA packaging, but pseudogenes like RN7SL614P are generally not expressed and lack biological or clinical significance[1][4].

Other names
RN7SL614PRNA, 7SL, cytoplasmic 614, pseudogene
02

Mechanism of action

None known

03

Biological functions

None for RN7SL614P (as a pseudogene)Canonical 7SL RNA functions include SRP assembly, regulation of protein targeting to the endoplasmic reticulum, and modulation of translation
04

Disease associations

None for RN7SL614PCanonical 7SL RNA is studied for roles in viral packaging (e.g., HIV, HBV), translation control, and possible links to cancer through related RNAs

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 614, pseudogene (RN7SL614P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 614, pseudogene (RN7SL614P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call